Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQInformation TechnologyInformation Technology ServicesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
12.01 → 12.06 EPS · FY ending Dec 31, 2027 · 7 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 7 to 7; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for CDW yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Increase share repurchase program by $1 billion | A supporting condition in CDW Corporation's published investment case. The stated target is Maintain or increase $1B share repurchase authorization. | Intact | No further buyback authorization or reduction in repurchase program | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
CDW is a technology distributor with a growth-and-cash-generation thesis, rather than a turnaround story. The long-term thesis is intact, but confidence is medium because management execution has been volatile and risk is elevated.
The valuation is described as cheap versus peers, and it has fallen recently. The expectations gap is negative, while the priced-in assessment says current fragility is low and the setup is justified, not broadly fragile.
Over the multi-year view, management’s stated aim to grow 200 to 300 basis points faster than the US IT market remains on track, and operating cash flow has been generally strong but variable. Near term, recent performance is neutral and the miss risk is assessed as low, though recent misses and a possible guidance cut remain risks.
The thesis depends on CDW continuing to outgrow the US IT market and sustaining cash generation and working capital discipline. Near term, a guidance cut would be a meaningful negative, while Fed rate cuts or stabilization among major technology companies could improve the sector backdrop.
For the next 1 to 3 years, CDW’s growth and cash-generation case remains intact, but volatile execution and elevated risk temper the view. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Cash flow remains solid near $275 million quarterly. |
| Broken |
| quarterly cash from operations falls below $275M |
Cash from operations: $219.7M FY2026-Q2; GAAP. Published target: >=$275M cash from operations per quarter. Target period is not explicitly aligned with this observation. Aug 5, 2026219,700,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 8 of 8 supplied quarters. Management reported: ““We continue to balance investments that support our customers and long-term growth with disciplined expense management and capital allocation, providing flexibility to deliver shareholder value."” “"We continue to focus on balancing growth investments with operational efficiency while maintaining a disciplined approach to working capital and capital allocation, providing flexibility to support our customers and create long-term shareholder value."” Operating income was $489.500 million in 2026-Q3. Delivery assessment Nov 4, 2026 |
Revenue growth exceeding US IT market by 200-300 basis points | CDW grows revenue about 9% yearly, beating the US IT market by 2-3 points. | Intact | YoY revenue growth falls below 7% next year | Revenue growth: 17.73% FY2026-Q3; GAAP. Published target: >=7% YoY revenue growth. Target period is not explicitly aligned with this observation. Nov 4, 202617.727542 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 8 of 8 supplied quarters. Management reported: “"Our ability to address customers’ needs across the full technology stack and lifecycle, together with our continued strategic investments, reinforces our confidence in our ability to outpace US IT addressable market growth by 200 to 300 basis points on a constant currency basis and drive sustainable long-term value for our customers and shareholders."” “Supported by these strengths, we remain confident in our ability to exceed US IT addressable market growth by 200 to 300 basis points on a constant currency basis."” Revenue was $6.755 billion in 2026-Q3. Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$11.78 → $12.06 · observed estimates
$24.39B → $25.24B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $11.78 | $24,385,333,510 | 10 / 9 |
| 2026-07-25 | $11.78 | $24,385,333,510 | 10 / 9 |
| 2026-07-26 | $11.78 | $24,385,333,510 | 10 / 9 |
| 2026-07-27 | $11.78 | $24,385,333,510 | 10 / 9 |
| 2026-07-28 | $11.78 | $24,385,333,510 | 10 / 9 |
| 2026-07-29 | $11.78 | $24,385,333,510 | 10 / 9 |
| 2026-07-30 | $11.78 | $24,385,333,512 | 7 / 7 |
| 2026-07-31 | $11.78 | $24,385,333,512 | 7 / 7 |
| 2026-08-01 | $11.78 | $24,385,333,512 | 7 / 7 |
| 2026-08-02 | $11.78 | $24,385,333,510 | 10 / 9 |
| 2026-08-03 | $11.78 | $24,385,333,512 | 7 / 7 |
| 2026-08-04 | $11.78 | $24,385,333,512 | 7 / 7 |
| 2026-08-05 | $11.78 | $24,385,333,512 | 7 / 7 |
| 2026-08-06 | $11.78 | $24,385,333,512 | 7 / 7 |
| 2026-08-07 | $11.84 | $24,875,939,576 | 7 / 7 |
| 2026-08-08 | $11.91 | $25,090,998,210 | 10 / 9 |
| 2026-08-09 | $11.84 | $24,875,939,576 | 7 / 7 |
| 2026-08-10 | $11.84 | $24,875,939,576 | 7 / 7 |
| 2026-08-11 | $11.84 | $24,875,939,576 | 7 / 7 |
| 2026-08-12 | $11.84 | $24,875,939,576 | 7 / 7 |
| 2026-08-13 | $11.84 | $24,875,939,576 | 7 / 7 |
| 2026-08-14 | $11.84 | $24,875,939,576 | 7 / 7 |
| 2026-08-15 | $11.84 | $24,875,939,576 | 7 / 7 |
| 2026-08-16 | $11.84 | $24,875,939,576 | 7 / 7 |
| 2026-08-17 | $11.84 | $24,875,939,576 | 7 / 7 |
| 2026-08-18 | $11.84 | $24,875,939,576 | 7 / 7 |
| 2026-08-19 | $11.84 | $24,875,939,576 | 7 / 7 |
| 2026-08-20 | $11.94 | $25,133,741,376 | 7 / 7 |
| 2026-08-21 | $11.94 | $25,133,741,376 | 7 / 7 |
| 2026-08-22 | $11.94 | $25,133,741,376 | 7 / 7 |
| 2026-08-23 | $11.94 | $25,133,741,376 | 7 / 7 |
| 2026-08-24 | $11.94 | $25,133,741,376 | 7 / 7 |
| 2026-08-25 | $11.94 | $25,133,741,376 | 7 / 7 |
| 2026-08-26 | $11.94 | $25,133,741,376 | 7 / 7 |
| 2026-08-27 | $11.94 | $25,133,741,376 | 7 / 7 |
| 2026-08-28 | $11.94 | $25,133,741,376 | 7 / 7 |
| 2026-08-29 | $11.94 | $25,133,719,153 | 7 / 7 |
| 2026-08-30 | $11.94 | $25,133,719,153 | 7 / 7 |
| 2026-08-31 | $11.94 | $25,133,719,153 | 7 / 7 |
| 2026-09-01 | $11.94 | $25,133,719,153 | 7 / 7 |
| 2026-09-02 | $11.94 | $25,133,719,153 | 7 / 7 |
| 2026-09-03 | $11.94 | $25,133,719,153 | 7 / 7 |
| 2026-09-04 | $11.94 | $25,133,719,153 | 7 / 7 |
| 2026-09-05 | $11.94 | $25,133,719,153 | 7 / 7 |
| 2026-09-06 | $11.94 | $25,133,719,153 | 7 / 7 |
| 2026-09-07 | $11.94 | $25,133,719,153 | 7 / 7 |
| 2026-09-08 | $11.94 | $25,133,719,153 | 7 / 7 |
| 2026-09-09 | $12.05 | $25,133,719,153 | 7 / 7 |
| 2026-09-10 | $12.05 | $25,133,719,153 | 7 / 7 |
| 2026-09-11 | $12.05 | $25,133,719,153 | 7 / 7 |
| 2026-09-12 | $12.05 | $25,133,719,153 | 7 / 7 |
| 2026-09-13 | $12.05 | $25,133,719,153 | 7 / 7 |
| 2026-09-14 | $12.05 | $25,133,719,153 | 7 / 7 |
| 2026-09-15 | $12.05 | $25,133,719,153 | 7 / 7 |
| 2026-09-16 | $12.05 | $25,133,719,153 | 7 / 7 |
| 2026-09-17 | $12.05 | $25,133,719,153 | 7 / 7 |
| 2026-09-18 | $12.05 | $25,133,719,153 | 7 / 7 |
| 2026-09-19 | $12.05 | $25,133,719,153 | 7 / 7 |
| 2026-09-20 | $12.05 | $25,133,719,153 | 7 / 7 |
| 2026-09-21 | $12.05 | $25,133,719,153 | 7 / 7 |
| 2026-09-22 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-09-23 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-09-24 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-09-25 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-09-26 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-09-27 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-09-28 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-09-29 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-09-30 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-10-01 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-10-02 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-10-03 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-10-04 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-10-05 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-10-06 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-10-07 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-10-08 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-10-09 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-10-10 | $12.01 | $25,133,719,153 | 7 / 7 |
| 2026-10-11 | $12.04 | $25,210,776,747 | 7 / 7 |
| 2026-10-12 | $12.04 | $25,210,776,747 | 7 / 7 |
| 2026-10-13 | $12.04 | $25,210,776,747 | 7 / 7 |
| 2026-10-14 | $12.04 | $25,210,776,747 | 7 / 7 |
| 2026-10-15 | $12.04 | $25,210,776,747 | 7 / 7 |
| 2026-10-16 | $12.04 | $25,210,776,747 | 7 / 7 |
| 2026-10-17 | $12.04 | $25,210,776,747 | 7 / 7 |
| 2026-10-18 | $12.04 | $25,210,776,725 | 7 / 7 |
| 2026-10-19 | $12.04 | $25,210,776,725 | 7 / 7 |
| 2026-10-20 | $12.04 | $25,210,776,725 | 7 / 7 |
| 2026-10-21 | $12.04 | $25,210,776,725 | 7 / 7 |
| 2026-10-22 | $12.04 | $25,210,776,725 | 7 / 7 |
| 2026-10-23 | $12.04 | $25,210,776,725 | 7 / 7 |
| 2026-10-24 | $12.06 | $25,244,998,947 | 7 / 7 |
| 2026-10-25 | $12.06 | $25,244,998,947 | 7 / 7 |
| 2026-10-26 | $12.06 | $25,244,998,947 | 7 / 7 |
| 2026-10-27 | $12.06 | $25,244,998,947 | 7 / 7 |
| 2026-10-28 | $12.06 | $25,244,998,947 | 7 / 7 |
| 2026-10-29 | $12.06 | $25,244,998,947 | 7 / 7 |
| 2026-10-30 | $12.06 | $25,244,998,947 | 7 / 7 |
| 2026-10-31 | $12.06 | $25,244,998,947 | 7 / 7 |
| 2026-11-01 | $12.06 | $25,244,998,947 | 7 / 7 |
| 2026-11-02 | $12.06 | $25,244,998,947 | 7 / 7 |
| 2026-11-03 | $12.06 | $25,244,998,947 | 7 / 7 |
| 2026-11-04 | $12.06 | $25,244,998,947 | 7 / 7 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 7 Buy / Strong Buy · 3 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.